ES2192764T3 - Mimeticos de lamina beta y metodos relacionados con el uso de los mismos. - Google Patents

Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.

Info

Publication number
ES2192764T3
ES2192764T3 ES98908551T ES98908551T ES2192764T3 ES 2192764 T3 ES2192764 T3 ES 2192764T3 ES 98908551 T ES98908551 T ES 98908551T ES 98908551 T ES98908551 T ES 98908551T ES 2192764 T3 ES2192764 T3 ES 2192764T3
Authority
ES
Spain
Prior art keywords
beta
same
mimetics
lamina
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98908551T
Other languages
English (en)
Inventor
Maher N Qaber
Michael K Mcmillian
Michael S Kahn
John E Tulinsky
Jessymol Mathew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecumetics Ltd
Original Assignee
Molecumetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecumetics Ltd filed Critical Molecumetics Ltd
Application granted granted Critical
Publication of ES2192764T3 publication Critical patent/ES2192764T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención está dirigida a miméticos de lámina beta y al uso de los mismos, incluyendo el uso para la preparación de un medicamento para conseguir efectos terapéuticos en un animal de sangre caliente, a través de una o más de: inhibición de proteasa, inhibición de cinasa, regulación de un factor de transcripción y/o inhibición de interacciones de fijación proteína-proteína. Los efectos terapéuticos son originados por la administración al animal de sangre caliente de una cantidad terapéuticamente eficaz de un mimético de lámina beta que tiene la estructura general indicada en la reivindicación 1. Esta estructura incluye un sistema anular bicíclico, de estructura general (I) (incluyendo las sales farmacéuticamente aceptables del mismo):
ES98908551T 1998-02-12 1998-02-12 Mimeticos de lamina beta y metodos relacionados con el uso de los mismos. Expired - Lifetime ES2192764T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002891 WO1999041276A1 (en) 1998-02-12 1998-02-12 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF

Publications (1)

Publication Number Publication Date
ES2192764T3 true ES2192764T3 (es) 2003-10-16

Family

ID=22266392

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98908551T Expired - Lifetime ES2192764T3 (es) 1998-02-12 1998-02-12 Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.

Country Status (9)

Country Link
EP (1) EP1053246B1 (es)
JP (1) JP2002503674A (es)
KR (1) KR20010040939A (es)
AT (1) ATE230414T1 (es)
AU (1) AU748887B2 (es)
CA (1) CA2319766A1 (es)
DE (1) DE69810513T2 (es)
ES (1) ES2192764T3 (es)
WO (1) WO1999041276A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525294A (ja) * 2000-02-29 2003-08-26 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Ｃ型肝炎ウイルスｎｓ３プロテアーゼの阻害剤
US6534651B2 (en) 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US20060276497A1 (en) 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
WO2003068237A1 (en) * 2002-02-14 2003-08-21 Myriad Genetics, Inc. Beta-sheet mimetics and composition and methods relating thereto
JP2011525927A (ja) * 2008-06-25 2011-09-29 シェーリング コーポレイション 複素環式抗菌剤の合成および使用
WO2016057413A2 (en) 2014-10-06 2016-04-14 Cortexyme, Inc. Inhibitors of lysine gingipain
WO2017083433A1 (en) 2015-11-09 2017-05-18 Cortexyme, Inc. Inhibitors of arginine gingipain
RU2742771C2 (ru) 2016-08-31 2021-02-10 Цзянсу Хэнжуй Медицин Ко., Лтд. Производное оксопиколинамида, способ его получения и его фармацевтическое применение
MX2019003087A (es) 2016-09-16 2019-08-12 Cortexyme Inc Inhibidores cetónicos de gingipain de lisina.
US11225462B2 (en) 2018-07-02 2022-01-18 Jiangsu Hengrui Medicine Co., Ltd. Crystal forms of oxypyridine amide derivative and preparation method therefor
JP7450024B2 (ja) 2019-09-27 2024-03-14 シェンヅェン サルブリス ファーマシューティカルズ カンパニー リミテッド ＦＸＩａ阻害剤及びその調製方法と医薬用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117123T3 (es) * 1992-02-14 1998-08-01 Merrell Pharma Inc Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
NZ251930A (en) * 1992-05-15 1996-02-27 Merrell Dow Pharma Mercaptoacetylamido pyridazo[1,2]pyridazine, pyrazolo[1,2]pyridazine, pyridazo[1,2-a]diazepine and pyrazolo[1,2-a]diazepine derivatives, pharmaceutical compositions and preparatory methods
EP0618223A3 (en) * 1993-03-08 1996-06-12 Sandoz Ltd Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents.
AU4250596A (en) * 1994-12-22 1996-07-10 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
ES2161354T3 (es) * 1995-03-24 2001-12-01 Molecumetics Ltd Compuestos mimeticos de la hoja beta y su uso como inhibidores de proteasas.
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
ES2262184T3 (es) * 1996-08-05 2006-11-16 Myriad Genetics, Inc. Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.

Also Published As

Publication number Publication date
ATE230414T1 (de) 2003-01-15
JP2002503674A (ja) 2002-02-05
WO1999041276A1 (en) 1999-08-19
KR20010040939A (ko) 2001-05-15
DE69810513T2 (de) 2004-03-18
EP1053246B1 (en) 2003-01-02
AU6655798A (en) 1999-08-30
CA2319766A1 (en) 1999-08-19
AU748887B2 (en) 2002-06-13
EP1053246A1 (en) 2000-11-22
DE69810513D1 (de) 2003-02-06

Similar Documents

Publication Publication Date Title
NO990522D0 (no) Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ECSP055525A (es) Inhibidores de cinasas de tirosina
UY26092A1 (es) Uso de inhibidores de cyp2d6 en terapias de combinacion
NO20013444D0 (no) Triazolforbindelser med dopamin-D3-reseptor-affinet
ECSP056194A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa
BRPI0313733A8 (pt) Uso da proteína n beta cinase
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
CY1105917T1 (el) Αναλογα ομοιου με γλυκαγονη πεπτιδιου-1
ES2192764T3 (es) Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
ATE231872T1 (de) Thiazolopyrimidinderivate
SE0101932D0 (sv) Pharmaceutical combinations
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
HUP0202592A2 (hu) Lazofoxifen transzdermális adagolása
ATE374203T1 (de) Therapeutische verbindungen und verfahren
CY1106363T1 (el) Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων
NO20005548L (no) Mykobakterieinhibitorer